Evaluation of oxidative stress in overweight subjects with or without metabolic syndrome

Obesity

Volumn 20, Issue 12, 2012, Pages 2361-2366

  Venturini, Danielle ^a   Simão, Andréa N C ^a   Scripes, Nicole A ^a   Bahls, Larissa D ^a   Melo, Petrônio A S ^a   Belinetti, Francine M ^a   Lozovoy, Marcell A B ^b   Dichi, Isaias ^a  

^a University Hospital of Londrina   (Brazil)

^b North University of Paraná UNOPAR   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; HYDROGEN PEROXIDE; HYDROPEROXIDE; URIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CHEMOLUMINESCENCE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OXIDATION REDUCTION STATE; OXIDATIVE STRESS;

ADULT; ANTIOXIDANTS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OVERWEIGHT; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 84870294009     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.130     Document Type: Article

References (33)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
2. Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
3. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008;28:629-636.
4. Ohmori K, Ebihara S, Kuriyama S et al. The relationship between body mass index and a plasma lipid peroxidation biomarker in an older, healthy Asian community. Ann Epidemiol 2005;15:80-84.
5. Urakawa H, Katsuki A, Sumida Y et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 2003;88:4673-4676.
6. Abdilla N, Tormo MC, Fabia MJ et al. Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension. J Hum Hypertens 2007;21:68-75.
7. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004;24:816-823.
8. Lee, K-U. Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract 2001;54 (Suppl 2):29-33.
9. Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-1761.
10. Skalicky J, Muzakova V, Kandar R et al. Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin Chem Lab Med 2008;46:499-505.
11. Krzystek-Korpackaa M, Patrynb E, Boehma D, Berdowskaa I, Zielinskia B, Noczynskab A. Advanced oxidation protein products (AOPPs) in juvenile overweight and obesity prior to and following weight reduction. Clin Biochem 2008;41:943-949.
12. Simão AN, Dichi JB, Barbosa DS, Cecchini R, Dichi I. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Nutrition 2008;24:675-681.
13. Jacobs DR Jr. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and high blood cholesterol in adults (Adults Treatment Panel III). JAMA 2001;285:2486-2497.
14. Haffner SM. Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol 2003;92:18J-26J.
15. Gonzalez Flecha B, Llesuy S, Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med 1991;10:93-100.
16. Casado MF, Cecchini AL, Simão AN, Oliveira RD, Cecchini R. Free radicalmediated pre-hemolytic injury in human red blood cells subjected to lead acetate as evaluated by chemiluminescence. Food Chem Toxicol 2007;45:945-952.
17. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 1994;220:403-409.
18. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-1313.
19. Repetto M, Reides C, Gomez Carretero ML et al. Oxidative stress in blood of HIV infected patients. Clin Chim Acta 1996;255:107-117.
20. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002;162:1867-1872.
21. Keaney JF Jr, Larson MG, Vasan RS et al.; Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003;23:434-439.
22. Piwowar A, Knapik-Kordecka M, Warwas M. AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus. Diabetes Res Clin Pract 2007;77:188-192.
23. Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006;70:1437-1442.
24. Lavoie M-E, Rabasa-Lhoret R, Ziai S, Lavoie J-C. Blood gluthatione peroxidase activity in relation with the risk of cardiovascular diseases in obese women. J Diabetes Metab 2011;2:136-141.
25. Hansel B, Giral P, Nobecourt E et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004;89:4963-4971.
26. Ceriello A. Oxidative stress and glycemic regulation. Metab Clin Exp 2000;49:27-29.
27. Simão AN, Lozovoy MA, Simão TN et al. Nitric oxide enhancement and blood pressure decrease in patients with metabolic syndrome using soy protein or fish oil. Arq Bras Endocrinol Metabol 2010;54:540-545.
28. Ando K, Fujita T. Metabolic syndrome and oxidative stress. Free Radic Biol Med 2009;47:213-218.
29. Meisinger C, Koenig W, Baumert J, Döring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol 2008;28:1186-1192.
30. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 2009;266:558-570.
31. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003;52:2346-2352.
32. Santos AC, Lopes C, Guimarães JT, Barros H. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Int J Obes (Lond) 2005;29:1452-1456.
33. Festa A, D'Agostino R Jr, Howard G et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-47.